Bharat Immunologicals and Biologicals Corporation Limited
(A Government of India Undertaking)
- BIBCOL is expected to formulate 100 million doses of OPV from bulk and supply to National Immunization Program during the year 2005-2006.
- Contribution for total elimination of polio from the country through continuous support to National Immunization Program.
- Expansion of Product Portfolio such as production of DPT, Measles, IPV and Hepatitis B Vaccines.
- Manufacture of various nutraceuticals and biologicals for treatment of health deficiencies and disorders.
Copyright @ 2006 Bibcol Goverment of India. All right reserved.